Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectSusan L Slager, Yolanda Benavente, Aaron Blair, et al.
Leukemia & Lymphoma|May 26, 2020
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practiceAmber B Koehler, Nelson Leung, Timothy G Call, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemiaTait D Shanafelt, Thomas E Witzig, Stephanie R Fink, et al.
British Journal of Haematology|September 16, 2009
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progressionWei Ding, Grzegorz S Nowakowski, Traci R Knox, et al.
Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.
American Journal of Hematology|April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cellsClive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
Mayo Clinic Proceedings|August 6, 2019
Etiologies of Extreme Thrombocytosis: A Contemporary SeriesRonan W Hsieh, Aishwarya Ravindran, Christopher C Hook, et al.
Blood|April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLLSameer A Parikh, Kari G Rabe, Neil E Kay, et al.
Leukemia Research|July 31, 2007
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaRebekah L Browning, Susan M Geyer, Amy J Johnson, et al.
The Oncologist|September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic LeukemiaPaul J Hampel, Timothy G Call, Kari G Rabe, et al.
Pageof 18